Rahim Shabana, Dhrolia Murtaza, Qureshi Ruqaya, Nasir Kiran, Ahmad Aasim
Nephrology, The Kidney Centre Post Graduate Training Institute, Karachi, PAK.
Cureus. 2022 Jan 23;14(1):e21512. doi: 10.7759/cureus.21512. eCollection 2022 Jan.
This study aims to compare the characteristics and outcomes of the first and second waves of coronavirus disease 2019 (COVID-19) in hemodialysis (HD) patients.
We compared the epidemiological, clinical, laboratory, and radiological characteristics and outcomes of a cohort of HD patients who contracted COVID-19 in our HD center during the first wave from May 2020 to September 2020 and the second wave from November 2020 to February 2021.
A total of 50 (11.8%) of 423 patients during the first wave and 46 (10.5%) of 437 patients during the second wave contracted COVID-19. The median age was 59.5 ± 9.99 years (first wave) and 60.3 ± 13.02 years (second wave). Most patients developed the mild disease. Patients requiring hospitalization (22% vs. 32.6%) and mechanical ventilation (10% vs. 17.4%) were more in the second wave. The most common symptom was fever (82% and 63%) in both waves. Patchy bilateral opacity was the most common radiological finding. Major complications including lymphocytopenia (36% and 63%), pneumonia (28% and 32.6%), thrombocytopenia (30% and 17.4%), and septic shock (6% and 10.9%) were shared. Ten (20%) patients died in the first wave and 13 (28.3%) in the second wave. Patients aged > 60 years had more severe disease and died more than patients aged < 60 years in both waves.
There is a high susceptibility and mortality of HD patients in both the first and second waves of COVID-19 as compared to the general population. Disease symptoms, radiological findings, and laboratory tests were similar in both waves. Patients developing critical disease and requiring hospitalization and mechanical ventilation were more in the second wave.
本研究旨在比较血液透析(HD)患者中2019冠状病毒病(COVID-19)第一波和第二波的特征及结局。
我们比较了2020年5月至2020年9月第一波以及2020年11月至2021年2月第二波期间在我们血液透析中心感染COVID-19的一组血液透析患者的流行病学、临床、实验室及影像学特征和结局。
第一波423例患者中有50例(11.8%)感染COVID-19,第二波437例患者中有46例(10.5%)感染。中位年龄第一波为59.5±9.99岁,第二波为60.3±13.02岁。大多数患者病情为轻症。第二波中需要住院治疗(22%对32.6%)和机械通气(10%对17.4%)的患者更多。两波中最常见的症状均为发热(分别为82%和63%)。双侧斑片状模糊影是最常见的影像学表现。主要并发症包括淋巴细胞减少(分别为36%和63%)、肺炎(分别为28%和32.6%)、血小板减少(分别为30%和17.4%)以及感染性休克(分别为6%和10.9%)。第一波中有10例(20%)患者死亡,第二波中有13例(28.3%)患者死亡。两波中年龄>60岁的患者病情更严重,死亡人数多于年龄<60岁的患者。
与普通人群相比,血液透析患者在COVID-19第一波和第二波中均具有较高的易感性和死亡率。两波中的疾病症状、影像学表现及实验室检查相似。第二波中出现危重症且需要住院治疗和机械通气的患者更多。